即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS号 | 468741-42-6 | 货号 | BCP02846 |
中文名 | BMS-554417 | ||
英文名 | BMS-554417 | ||
中文别名 | |||
英文别名 | BMS554417;BMS 554417; | ||
SMILES | |||
化学名称 | |||
分子式 | C28H30ClN7O2 | 分子量 | 532.04 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | BMS-554417 is a novel inhibitor of IGF-IR, which inhibits IGF-IR and insulin receptor kinase activity and proliferation in vitro, and reduces tumor xenograft size in vivo. In a series of carcinoma cell lines, the IC50 for proliferation ranged from 120 nmol/L (Colo205) to >8.5 micromol/L (OV202). BMS-554417 treatment inhibited IGF-IR and insulin receptor signaling through extracellular signal-related kinase as well as the phosphoinositide 3-kinase/Akt pathway, as evidenced by decreased Akt phosphorylation at Ser473. At doses that inhibited proliferation, the compound also caused a G0-G1 arrest and prevented nuclear accumulation of cyclin D1 in response to LR3 IGF-I. In Jurkat T-cell leukemia cells, this agent triggered apoptotic cell death via the mitochondrial pathway. BMS-554417 was orally bioavailable and significantly inhibited the growth of IGF1R-Sal tumor xenografts in vivo. BMS-554417 is a member of a novel class of IGF-IR/insulin receptor inhibitors that have potential clinical applications because of their antiproliferative and proapoptotic activity in vitro and in vivo. |
相关产品推荐
查看更多 >Tags:BMS-554417 供应商,BMS-554417 购买,BMS-554417 生产,BMS-554417 批量,BMS-554417 供应,BMS-554417 订购,BMS-554417 采购